search
Back to results

Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria (Hi-MAM)

Primary Purpose

Malnutrition

Status
Completed
Phase
Not Applicable
Locations
Sierra Leone
Study Type
Interventional
Intervention
amoxicillin
Ready-to-use therapeutic food (RUTF)
Mother Care group
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malnutrition

Eligibility Criteria

6 Months - 59 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • uncomplicated MAM (based on MUAC equal to or greater than 11.5 cm and <12.5)

Exclusion Criteria:

  • currently involved in another research trial or feeding program
  • medical complication such as oedema, severe nausea/vomiting, severe dehydration, or severe pneumonia
  • have a diagnosed or visible sign of developmental delay
  • have a history of peanut or milk allergy

Sites / Locations

  • Project Peanut Butter

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Moderate Acute Malnutrition (MAM)

High Risk Moderate Acute Malnutrition (MAM)

Arm Description

MAM children at control clinics or MAM children at intervention clinics that do no have high rick characteristics. Control treatment is "Mother Care" counselling, delivered by a respected elder in the local community.

The intervention treatment incorporates Mother Care counselling, provision of one packet (508 calories) of ready-to-use therapeutic food (RUTF) daily and a 1 week course of amoxicillin. This provision will continue until the child has reached a mid-upper arm circumference (MUAC) equal to or greater than 12.5 cm or 12 weeks have elapsed.

Outcomes

Primary Outcome Measures

Recovery from moderate acute malnutrition (MAM)
proportion of participants recovered based on mid-upper arm circumference(MUAC) Recovery is defined as MUAC greater than or equal to 12.5cm before or at 12 weeks after enrollment.

Secondary Outcome Measures

Participant survival rates
Proportion of participants survival rates during the study
Participants deterioration to severe acute malnutrition(SAM)
Proportion of participants that deteriorate from moderate acute malnutrition(MAM) to severe acute malnutrition(SAM). SAM is defined at mid-upper arm circumference(MUAC)<11.5 or presence of oedema.
Participants that remain or become underweight using weight for age z-score
the difference between the weight for age z-score(WAZ) from enrollment to 24 weeks post-enrollment
Participants that remain or become Stunted
the difference between length for age z-score(LAZ) from enrollment to 24 weeks post enrollment
Participants that remain or become Wasted
the difference between weight for length z-score(WHL) from enrollment to 24 weeks post enrollment
Eye tracking performance for cognitive development
the difference between the eye tracking performance from enrollment to 24 weeks post enrollment

Full Information

First Posted
July 31, 2018
Last Updated
August 29, 2020
Sponsor
Washington University School of Medicine
Collaborators
Centre for Global Child Health, Hospital for Sick Kids, Toronto, Canada, Department of Psychology, University of Tampere, Finland, Project Peanut Butter, Sierra Leone
search

1. Study Identification

Unique Protocol Identification Number
NCT03647150
Brief Title
Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria
Acronym
Hi-MAM
Official Title
Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria (Hi-MAM Study): A Cluster-randomized Controlled Trial Protocol
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
November 13, 2018 (Actual)
Primary Completion Date
June 5, 2020 (Actual)
Study Completion Date
June 5, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
Centre for Global Child Health, Hospital for Sick Kids, Toronto, Canada, Department of Psychology, University of Tampere, Finland, Project Peanut Butter, Sierra Leone

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This project explores whether children have better growth and cognitive development when the clinic identifies "higher risk" MAM children and support them either with the same treatment as SAM children or with the recommended practice: nutrition counseling.
Detailed Description
This is a cluster-randomized controlled trial taking place in 20 community clinics providing malnutrition care in Sierra Leone. All participants will be children aged 6-59 months. Control participants will have moderate acute malnutrition (MAM), defined as mid-upper arm circumference (MUAC) 11.5-<12.5. High Risk MAM will be defined with a MUAC 11.5 to <11.9 or WAZ<-3.5 or Mother not the caretaker or not breastfeeding at <2 years old. Low risk MAM defined with a MUAC 11.9 to <12.5 with no risk factors. Control group and low risk group caregiver's will received nutrition education via mother care groups every two weeks for 6 weeks and will be followed up 12 and 24 weeks post-enrollment. High risk group will receive 1 week supply of amoxicillin at enrollment and 1 sachet of RUTF per day till MUAC is equal to or greater than 12.5 or up to 12 weeks of treatment. Their caregiver will also receive nutrition education via the mother care groups. The investigators will also follow up with the participant at 12 and 24 weeks post-enrollment. A subset of the participants in each group will also be enrolled in a cognitive development substudy were the investigators will be using a eye tracking performance assessment. Investigators will also enroll health adult participants for eye tracking assessment. Adult data will be used as a reference when interpreting results.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1322 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Moderate Acute Malnutrition (MAM)
Arm Type
Other
Arm Description
MAM children at control clinics or MAM children at intervention clinics that do no have high rick characteristics. Control treatment is "Mother Care" counselling, delivered by a respected elder in the local community.
Arm Title
High Risk Moderate Acute Malnutrition (MAM)
Arm Type
Experimental
Arm Description
The intervention treatment incorporates Mother Care counselling, provision of one packet (508 calories) of ready-to-use therapeutic food (RUTF) daily and a 1 week course of amoxicillin. This provision will continue until the child has reached a mid-upper arm circumference (MUAC) equal to or greater than 12.5 cm or 12 weeks have elapsed.
Intervention Type
Drug
Intervention Name(s)
amoxicillin
Intervention Description
At enrollment the child will receive a 1 week course of amoxicillin
Intervention Type
Dietary Supplement
Intervention Name(s)
Ready-to-use therapeutic food (RUTF)
Intervention Description
1 sachet RUTF per day (508 calories) till child MUAC is greater than 12.4 cm or 12 weeks have elapsed
Intervention Type
Behavioral
Intervention Name(s)
Mother Care group
Intervention Description
Nutrition education via mother care groups lead by a respected elder in the local community
Primary Outcome Measure Information:
Title
Recovery from moderate acute malnutrition (MAM)
Description
proportion of participants recovered based on mid-upper arm circumference(MUAC) Recovery is defined as MUAC greater than or equal to 12.5cm before or at 12 weeks after enrollment.
Time Frame
up to 12 weeks of treatment
Secondary Outcome Measure Information:
Title
Participant survival rates
Description
Proportion of participants survival rates during the study
Time Frame
Duration of the study 24 weeks post-enrollment
Title
Participants deterioration to severe acute malnutrition(SAM)
Description
Proportion of participants that deteriorate from moderate acute malnutrition(MAM) to severe acute malnutrition(SAM). SAM is defined at mid-upper arm circumference(MUAC)<11.5 or presence of oedema.
Time Frame
Duration of the study 24 weeks post-enrollment
Title
Participants that remain or become underweight using weight for age z-score
Description
the difference between the weight for age z-score(WAZ) from enrollment to 24 weeks post-enrollment
Time Frame
24 weeks post-enrollment
Title
Participants that remain or become Stunted
Description
the difference between length for age z-score(LAZ) from enrollment to 24 weeks post enrollment
Time Frame
24 weeks post-enrollment
Title
Participants that remain or become Wasted
Description
the difference between weight for length z-score(WHL) from enrollment to 24 weeks post enrollment
Time Frame
24 weeks post-enrollment
Title
Eye tracking performance for cognitive development
Description
the difference between the eye tracking performance from enrollment to 24 weeks post enrollment
Time Frame
24 weeks post enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
59 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: uncomplicated MAM (based on MUAC equal to or greater than 11.5 cm and <12.5) Exclusion Criteria: currently involved in another research trial or feeding program medical complication such as oedema, severe nausea/vomiting, severe dehydration, or severe pneumonia have a diagnosed or visible sign of developmental delay have a history of peanut or milk allergy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark Manary, MD
Organizational Affiliation
Washington University School of Medicine in St. Louis
Official's Role
Principal Investigator
Facility Information:
Facility Name
Project Peanut Butter
City
Freetown
Country
Sierra Leone

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
4839581
Citation
Joshua GE, Jadhav M, Bhaktaviziam A, Mokashi S. Mental retardation in children. II. Leucodystrophies. Indian Pediatr. 1974 Jan;11(1):53-9. No abstract available.
Results Reference
background
PubMed Identifier
24564235
Citation
Lenters LM, Wazny K, Webb P, Ahmed T, Bhutta ZA. Treatment of severe and moderate acute malnutrition in low- and middle-income settings: a systematic review, meta-analysis and Delphi process. BMC Public Health. 2013;13 Suppl 3(Suppl 3):S23. doi: 10.1186/1471-2458-13-S3-S23. Epub 2013 Sep 17.
Results Reference
background
PubMed Identifier
23256140
Citation
Chang CY, Trehan I, Wang RJ, Thakwalakwa C, Maleta K, Deitchler M, Manary MJ. Children successfully treated for moderate acute malnutrition remain at risk for malnutrition and death in the subsequent year after recovery. J Nutr. 2013 Feb;143(2):215-20. doi: 10.3945/jn.112.168047. Epub 2012 Dec 19.
Results Reference
background
PubMed Identifier
26423737
Citation
Maust A, Koroma AS, Abla C, Molokwu N, Ryan KN, Singh L, Manary MJ. Severe and Moderate Acute Malnutrition Can Be Successfully Managed with an Integrated Protocol in Sierra Leone. J Nutr. 2015 Nov;145(11):2604-9. doi: 10.3945/jn.115.214957. Epub 2015 Sep 30.
Results Reference
background
PubMed Identifier
17032722
Citation
Ekelund U, Ong KK, Linne Y, Neovius M, Brage S, Dunger DB, Wareham NJ, Rossner S. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab. 2007 Jan;92(1):98-103. doi: 10.1210/jc.2006-1071. Epub 2006 Oct 10.
Results Reference
background
PubMed Identifier
28944990
Citation
Khara T, Mwangome M, Ngari M, Dolan C. Children concurrently wasted and stunted: A meta-analysis of prevalence data of children 6-59 months from 84 countries. Matern Child Nutr. 2018 Apr;14(2):e12516. doi: 10.1111/mcn.12516. Epub 2017 Sep 25.
Results Reference
background
PubMed Identifier
8706239
Citation
Schofield C, Ashworth A. Why have mortality rates for severe malnutrition remained so high? Bull World Health Organ. 1996;74(2):223-9.
Results Reference
background
PubMed Identifier
33963734
Citation
Lelijveld N, Godbout C, Krietemeyer D, Los A, Wegner D, Hendrixson DT, Bandsma R, Koroma A, Manary M. Treating high-risk moderate acute malnutrition using therapeutic food compared with nutrition counseling (Hi-MAM Study): a cluster-randomized controlled trial. Am J Clin Nutr. 2021 Sep 1;114(3):955-964. doi: 10.1093/ajcn/nqab137.
Results Reference
derived
Links:
URL
https://esa.un.org/unpd/wpp/DataQuery/
Description
United Nations Department of Economic and Social Affairs, P.D. World Population Prospectus 2017. 2017
URL
http://www.who.int/maternal_child_adolescent/documents/IMCI_chartbooklet/en/
Description
WHO. IMCI chart booklet. 2014

Learn more about this trial

Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria

We'll reach out to this number within 24 hrs